RxDoctor Payments Data

Alice Spina

Physician Assistant · Budd Lake, NJNPI 1760725998

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 310 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,890in general payments, 2019–2025

Across 310 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • AbbVie$682
  • Pfizer$432
  • GSK$422
  • Bayer$307
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$5,83699%
  • Education$541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,890 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$36,738
FarxigaDapagliflozin Propanediol15$19,077
Icosapent Ethyl11$2,643
Atorvastatin Calcium79$1,005
Rosuvastatin Calcium51$542
Metoprolol Succinate34$496
Levothyroxine Sodium42$375
Metformin Hcl ErMetformin Hcl26$358
Morphine Sulfate ErMorphine Sulfate11$354
Omeprazole26$246
Lorazepam14$242
Metformin Hcl34$194
Montelukast Sodium19$188
Gabapentin16$186
Citalopram HbrCitalopram Hydrobromide16$180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,225$36,73828 claims
AstraZenecaFarxiga$1,002$19,07715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Budd Lake

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →